Business Assessment (BA) is a collaborative team responsible for developing investment cases for pipeline and business development decisions. Its assessments are independent and apply consistent rigor whether they support or challenge a proposed investment. BA is part of Pfizer’s Global Commercial Analytics organization under the Chief Marketing Office, which brings together revenue forecasting across business development, in-line, and pipeline assets. The Director partners with commercial leadership, asset leads, Therapeutic Area Leadership Teams, and Worldwide Business Development to assess internal pipeline and external opportunities. The role independently leads multiple concurrent commercial assessments, including internal proof-of-concept study-start and Phase 3 business cases, external business development cases, and early pipeline forecasts. It provides strategic input on investment trade-offs, maintains consistency in forecasting approaches across internal and external opportunities, and presents analyses and recommendations to oncology leadership. The Director owns Oncology inputs to Operating Plan and Long-Range Forecast cycles and may also support other strategy projects, disease-area opportunities, M&A evaluations, emerging-technology platform assessments, and senior-management requests. The Director sets standards for AI-enabled assessment work, including evidence synthesis, competitive landscaping, model quality control, and executive materials, ensuring assumptions are traceable to their sources. The role also contributes to colleague development and may support additional Business Assessment, Global Commercial Analytics, and enterprise initiatives.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director